STAT5 induces miR-21 expression in cutaneous T cell lymphoma

Lise M. Lindahl(Novo Nordisk (Denmark)), Niels Ødum(LEO Foundation)

Oncotarget

June 18, 2016

10.18632/oncotarget.10160

Cited by 51

Related Papers

Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter

|American Journal Of Pathology|2000|128

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

|Oncotarget|2015|83

Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4 <sup>+</sup> T cells in cutaneous T-cell lymphoma

|OncoImmunology|2019|37

Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer

|Cancer Discovery|2025|5